EUVIMEDEUVIMED entdecken
Open Access

Development and Validation of Isocratic RP‐UHPLC Method for Assay of Fenofibrate Tablet

Jyoti Yadav iD, Saurav Kumar iD, Prabodh C Sharma, Parijat Pandey iD, Shivkant Sharma iD, Dhirender Kaushik iD

Biomedical Chromatography · 2026-09 · 40 (9)

DOI: 10.1002/bmc.70577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 28.07.2026. Verfasst von Jyoti Yadav und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sanskaram College of Pharmacy, Sanskaram University, Jhajjar, Haryana, India. Hauptthemen laut MEDLINE: Fenofibrate, Chromatography, Reverse-Phase. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A method developed and validated for the assay of fenofibrate in tablet dosage form by isocratic RP‐UHPLC–UV technique has been rapid and precise. The material was chromatographed on Shim‐pack Velox C18 column (50 × 2.1 mm, 1.8 μm) at 40°C with isocratic mobile phase: acidified water/acetonitrile (60:40, v/v) at 0.4 mL/min and at a detection wavelength of 286 nm. The total run time was 6.0 min and fenofibrate eluted at ~2.4 min. The method was linear over 10–90 μg/mL (r 2 = 0.9995) with LOD/LOQ of 0.239/0.673 μg/mL. The precision and accuracy (RSD less than 2% and 96%–100% recovery) comply with ICH Q2(R1) requirements both intra‐day and inter‐day. The present UHPLC method significantly shortens the analysis time and solvent consumption compared with the reported HPLC methods (typical run time > 8–20 min) without compromising of the sensitivity, which allows to use the present method for routine quality control of fenofibrate tablets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FenofibrateChromatography, Reverse-PhaseTabletsChromatography, High Pressure LiquidReproducibility of ResultsLimit of DetectionLinear Models

Stichwörter der Autor:innen

ICHUHPLCchromatographyfenofibratemethod developmentvalidation

Substanzen

FenofibrateTablets

Autor:innen und Institutionen

  • Sanskaram College of Pharmacy, Sanskaram University, Jhajjar, Haryana, India.
  • Department of Pharmaceutical Sciences, Gurugram University, Gurugram, Haryana, India.
  • Department of Pharmaceutical Sciences, Delhi Institute of Pharmaceutical Sciences and Research University, Delhi, India.

ORCID-Profile: Jyoti Yadav, Saurav Kumar, Parijat Pandey, Shivkant Sharma, Dhirender Kaushik

Zitieren

APA

Yadav, J., Kumar, S., Sharma, P. C., Pandey, P., Sharma, S., & Kaushik, D. (2026). Development and Validation of Isocratic RP‐UHPLC Method for Assay of Fenofibrate Tablet. Biomedical Chromatography, 40(9). https://doi.org/10.1002/bmc.70577

Vancouver

Yadav J, Kumar S, Sharma PC, Pandey P, Sharma S, Kaushik D. Development and Validation of Isocratic RP‐UHPLC Method for Assay of Fenofibrate Tablet. Biomedical Chromatography. 2026;40(9). doi:10.1002/bmc.70577

BibTeX
@article{Yadav2026,
  author = {Yadav, Jyoti and Kumar, Saurav and Sharma, Prabodh C and Pandey, Parijat and Sharma, Shivkant and Kaushik, Dhirender},
  title = {Development and Validation of Isocratic RP‐UHPLC Method for Assay of Fenofibrate Tablet},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {9},
  doi = {10.1002/bmc.70577}
}
Kostenlos starten →